Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.
Published July 25, 2012 · Recall initiated: March 9, 2012
Summary
FDA records drug Class III recall D-1422-2012, published July 25, 2012 and initiated March 9, 2012. Recalling firm: Pack Pharmaceuticals; Status: Terminated; Reported quantity: 4,848 bottles; Lot: Lot #: : PUB1040, Exp 08/2015. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
What to do
Voluntary: Firm initiated · Letter
Get an email if CIPROFLOXACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CIPROFLOXACIN
- Manufacturer
- Pack Pharmaceuticals
- Distributor
- Nationwide
- UPC
- 0316577411102
- Lot
- Lot #: : PUB1040, Exp 08/2015
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACiprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. BoxNovember 11, 2026
- FDACiprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O.November 11, 2026
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: LeadingMarch 26, 2025
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, DistributedJanuary 15, 2025
- FDAEpinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Use afterJuly 25, 2012
- FDAMidol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. blister, OTC, Distributed by BayerJuly 25, 2012
Questions about this recall
Was Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10. recalled?
Yes. FDA published recall D-1422-2012 on July 25, 2012. Reported hazard: Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CIPROFLOXACIN. UPC: 0316577411102.